FAS and hyperlipidemia: As shown in Fig. 7a-d, compared with those in the control group, the key regulator of liver lipid synthesis SREBP-1c and its related gene FAS/ACC expression levels were elevated in the liver of hyperlipidemia mice (P < 0.05).